A review of 640 Oral squamous cell carcinoma cases in Nigeria by Lawal, Ahmed O. et al.
J Clin Exp Dent. 2017;9(6):e767-71.                                                                                                                                                                   Oral squamous cell carcinoma in Nigeria
e767
Journal section: Oral Medicine and Pathology                           
Publication Types: Research
A review of 640 Oral squamous cell carcinoma cases in Nigeria
Ahmed-Oluwatoyin Lawal 1, Akinyele-Olumuyiwa Adisa 1, Olajumoke-Ajibola Effiom 2 
1 FMCDS. Senior Lecturer/Consultant, Department of Oral Pathology, College of Medicine, University of Ibadan, Nigeria
2 FMCDS. Senior Lecturer/Consultant, Department of Oral and Maxillofacial Pathology & Biology, College of Medicine, Univer-
sity of Lagos, Nigeria  
Correspondence:
Department of Oral Pathology
College of Medicine,University of Ibadan
lawaloluwatoyin@gmail.com
Received: 22/12/2016
Accepted: 14/04/2017
Abstract 
Background: Oral squamous cell carcinoma (OSCC) is the most prevalent malignant neoplasm in the oral cavity 
and accounts for 70% to 90% of all oral malignant neoplasms. The aim of this study was to examine the demogra-
phic distribution of OSCC in five Tertiary Health centres in Nigeria.
Material and Methods: All cases diagnosed as OSCC during the period from 1970 -2014 were retrieved from the 
records of five teaching hospitals in Nigeria. Hematoxylin and eosin stained histological slides of all cases that had 
a diagnosis of OSCC were reviewed for confirmation and inclusion. Data from all the centers was collated at the 
University College Hospital, Ibadan by 2 researchers. The data was entered into and analyzed with the SPSS for 
Windows (version 20.0; SPSS Inc. Chicago, IL).  Simple descriptive and comparative analyses were done, with the 
test of statistical significance set at p ≤ 0.05.
Results: A total of 640 cases of OSCC were seen out of 1560 oral malignant neoplasms representing 41% of all the 
oral malignancies seen. The mean age of occurence of OSCC was 55.5 (±17.0) years and a peak age incidence in 
the sixth and seventh decades of life. OSCC occurred more in males (60.9%) than females (39.1%) with a male: 
female ratio of 1.6:1. The well differentiated OSCC with 309 (48.3%) cases, was the most common grade, while 
the moderately differentiated and poorly differentiated OSCC accounted for 232 (36.2%) and 92 (14.4%) cases 
respectively 
Conclusions: This study showed that OSCC is more common in males, most commonly seen in the 60-69 age group 
and the commonest site of occurrence was the mandibular mucosa. The well differentiated OSCC was the most 
common histology sub-type.
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Introduction
According to World Health Organization, carcinoma of 
oral cavity in males in developing countries, is the sixth 
commonest cancer after lung, prostrate, colorectal, sto-
mach and bladder cancer, while in females, it is the tenth 
commonest site of cancer after breast, colorectal, lung, 
stomach, uterus, cervix, ovary, bladder and liver (1). In 
the oral cavity, oral squamous cell carcinoma (OSCC) 
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is the most prevalent malignant neoplasm and has been 
reported to account for 70% to 90% of all oral malignant 
neoplasms (2,3). There is global variation in the inci-
dence of OSCC with the Indian sub-continent presenting 
with particularly high incidence and prevalence, presu-
mably, because of the predominant habits of chewing 
tobacco, betel quid and areca-nut (4).
OSCC occurs most often in males who are above 40 years 
of age (5,6). Some authors have reported that up to 98% 
occurs above 40 years of age, with the incidence rising 
from an overall average of 3-4 cases per 100,000 per an-
num at all ages, to 100 cases per 100,000 per annum in 
those over 75 years of age (7). However, early exposure 
to tobacco use in western countries and habitual abuse of 
smokeless tobacco by teenagers in the Indian subconti-
nent has caused an increase incidence of OSCC amongst 
younger people (7,8). More so, the increasing incidence of 
OSCC in young people and especially in those who do not 
smoke or use alcohol has been associated with increased 
infection by Human Papilloma Virus (HPV) occasioned 
by changing sexual preference of young people (9).
The aim of this study was to analyse the demographic 
distribution of OSCC in five tertiary Health facilities in 
Nigeria.
Material and Methods
All cases diagnosed as OSCC during the period from 
1970 -2014 were retrieved from the records of the Uni-
versity Teaching Hospitals of Lagos, Ile-Ife, Ibadan, 
Port Harcourt, and Zaria. Hematoxylin and eosin stai-
ned histological slides of all cases that had a diagnosis 
of OSCC were reviewed for confirmation and inclusion. 
Researchers in each center retrieved records to obtain 
age, gender and location. The lesions were classified 
into; well differentiated, moderately differentiated and 
Age group Male Female Total (%)
0-9 2.0 2.0 4.0 (0.6)
10-19 4.0 7.0 11.0 (1.7)
20-29 22.0 10.0 32.0 (5.0)
30-39 42.0 23.0 65.0 (10.2)
40-49 59.0 32.0 91.0 (14.2)
50-59 79.0 49.0 128.0 (20.0)
60-69 90.0 57.0 147.0 (23.0)
70-79 63.0 46.0 109.0 (17.0)
80-89 20.0 15.0 35.0 (5.5)
90-99 4.0 4.0 8.0 (1.3)
100 2.0 0.0 2.0 (0.3)
missing - - 8.0 (1.3)
Total (%) 395 (61.7) 245 (38.3) 640 (100.0)
poorly differentiated according to broder’s classifica-
tion. Included parameters were documented according 
to a proforma designed by the researchers. Data from all 
the centers was collated at the University College Hos-
pital, Ibadan by 2 researchers. The data was entered into 
and analyzed with the SPSS software version 20. Simple 
descriptive and comparative analyses were done, with 
the test of statistical significance set at p ≤ 0.05. Ethical 
approval for the study was obtained from the UI/UCH 
Ethical Review Committee.
Results
A total of 640 cases of OSCC were seen out  of 1560 
oral malignant neoplasms representing 41% of all the 
oral malignacies seen at the 5 centres. OSCC occured 
with an age range of 4-108 years with a mean age of 
55.5 (±17.0) years and a peak age incidence in the sixth 
and seventh decades of life both accounting for 43.0% of 
total number of cases seen. Table 1 shows age and gen-
der distribution of OSCC from the five centres. OSCC 
was seen more in males (60.9%) than females (39.1%) 
with a male:female ratio of 1.6:1. The mean age for ma-
les was 54.8±16.4 whilst that for females was 56.7±17.7 
but there was no statistically significant difference in the 
mean ages between males and females (p=0.24). Table 
2 shows the site distribution of OSCC; the mandible 
with 169 (26.4%)  cases was the most common site of 
occurrence followed by the maxillary gingiva with 109 
(17.0%) cases. The palate recorded 92 (14.4%)  cases 
whilst 59 (9.2%)  and 27 (4.2%) cases ocurred in the 
tongue and floor mouth respectively.
Concerning Histologic grade, well differentiated OSCC 
with 309 (48.3%) cases, was the most common grade, 
while the moderately differentiated and poorly differen-
tiated OSCC accounted for 232 (36.2%) and 92 (14.4%) 
Table 1: Age and gender distribution of OSCC cases.
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cases respectively (Table 3). The well differentiated 
OSCC occurred at peak age of 60-69 and had a mean 
age of 55.6±16.8 while the moderately differentiated 
OSCC occurred at peak age of 60-69 had a mean age 
of 56.7±16.43. In the same vein, poorly differentiated 
OSCC had mean age of presentation of 51.7±18.2 and 
had a peak age incidence of 40-49. However, there was 
Site Number of patients Percentage
Mandible 169.0 26.4
Maxilla 109.0 17.0
Antrum 55.0 8.6
Buccal mucosa 46.0 7.2
Palate 92.0 14.4
Tongue 59.0 9.2
Floor of mouth 27.0 4.2
Lip 33.0 5.2
Gingiva 22.0 3.4
Metastatic disease 2.0 0.3
Submandibular gland 4.0 0.6
Parotid 8.0 1.3
Face 5.0 0.8
Total 631.0 98.6
missing 9.0 1.4
640 100.0
Table 2: Site distribution of OSCC.
Histologic grade No (%) M/F Age range/
mean Age
Peak age Commonest sites (%)
Well Diff 309 (48.3)
M,183 (59.2)
F, 125 (40.5)
M: F =1.4:1
9-100
55.6±16.8
Median=60.0
60-69
Mand (28.5)
Palate (15.2)
Max (13.9)
Moderately Diff 232 (36.3) M,133
F, 99
M: F=1.3:1
12-94
56.7±16.43
Median=58.0
60-69 Mand (24.1)
Maxilla (17.2)
Palate (14.2)
Poorly Diff 92 (14.4) M,68
F,24
M: F=2.8:1
4-90
51.7±18.2
Median=50.0
40-49 Mand (26.1)
Max (28.3)
Palate (12.0)
missing 7 (1.1)
Table 3: Sex, age and site distribution according to histologic grade.
M=male, F=female, Mand=mandible, Max=maxilla, diff=differentiated.
no statistically significant difference in age between his-
tological grades of OSCC (p=0.43, using one way ano-
va). Although, OSCC occurred more in males in all 3 
Histologic grades, the poorly differentiated OSCC had a 
much higher male: female ratio of 2.8:1, compared with 
1.4:1 and 1.3:1 for well differentiated OSCC and mode-
rately differentiated respectively.
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Discussion
Oral malignant neoplasms constitute a significant global 
health problem with reports signifying that they are the 
sixth most common malignancies worldwide and, toge-
ther with malignancy of the pharynx, are the third most 
common malignancies in the developing world (10). The 
finding of this study that OSCC constitutes 41% of all 
oral malignancies was in sharp contrast to most previous 
studies which showed that OSCC accounts for 70-95% 
of all oral malignancies (3,11-13). However, our finding 
was consistent with that of Ajayi et al. (8) who reported 
that OSCC accounts for 44% of all oral malignancies. 
The reason for the wide disparity in the relative frequen-
cy of OSCC in this study compared to most other studies 
is not immediately apparent, but subtle difference in ae-
tiology and predisposing factors are suggested.
The tongue is generally regarded as the commonest site 
of occurrence for OSCC. Santos et al. (14) suggested 
that consumption of alcohol from an early age may ac-
count for up to 40% of OSCC in the tongue as repor-
ted in their study in Brazil. Choi et al. (15) from Korea, 
Dimba et al. (16) from Kenya and Iamaroon et al. (17) 
from Thailand also reported 20.4%, 20.1% and 42.8% 
occurrence of OSCC in the tongue respectively. Howe-
ver, results from this present study found that the man-
dibular mucosa with 26.4% of cases was the most com-
mon site while only 9.2% occurred in the tongue which 
was in agreement with studies by Chidzonga et al. (3) 
and Effiom et al. (18) who reported highest incidence in 
the mandibular gingiva with values of 21.1% and 31.8% 
in mandibular gingiva respectively. The reason for the 
relatively high rate of occurrence of OSCC in the man-
dibular mucosa, the floor of mouth and tongue has been 
related to the fact that carcinogens in tobacco, alcohol, 
or foods dissolve in saliva and tend to pool in gravity 
dependent areas of the mouth (18). The reason for the 
disparities in the occurrence of OSCC in the mandibular 
mucosa, the tongue and floor of mouth from different stu-
dies, however, needs to be further investigated. The Lip is 
an uncommon site for OSCC in blacks (18) because of the 
protective effect of melanin and this is confirmed in this 
study with only 3.6% OSCC occurring in the Lip. Santos 
et al. (14) reported a 31.6% occurrence in the lower lip 
and thought that this might be due to the high exposure of 
their patients to sunlight radiation as the region of study 
was in close proximity to the equatorial line.
In the present study, the finding of a peak age incidence 
for OSCC in the 60-69 age group was in consonance with 
reports that OSCC occurred in older patients. Also, only 
17.3% of cases were seen below 40 years of age. This 
seems to confirms the long-held view that OSCC is seen 
more in older people as reported in several previous stu-
dies (19-22). On the contrary, a study by Effiom et al. in 
Lagos found a peak age incidence in the 40-49 age group 
and 40% occurrence of OSCC below the age of 40 years. 
The well differentiated OSCC with 48.3% of cases was 
the most common histology grade while the poorly di-
fferentiate grade with 14.4% was the least common in 
this study. This was in agreement with previous studies 
that found well differentiated OSCC to be the most com-
mon histologic grade and the poorly differentiated grade 
to be the least (3). On the contrary, Effiom et al. found 
the poorly differentiate grade (47.6%) to be the commo-
nest and the moderately differentiated (19.7%) as the 
least common. 
This multicentre study showed that OSCC is more com-
mon in males, most commonly seen in the 60-69 age 
group and the commonest site of occurrence was the 
mandibular mucosa. The well differentiated OSCC was 
the most common histology sub-type. However, the di-
fferences between some of our findings and some pre-
vious studies from Nigeria, such as peak age of occu-
rrence and the most common histologic sub-type, need 
further investigation.
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